ATP13A3 and Parkinson disease: Strikingly, ATP13A2 mutations are not implicated in cardiovascular but in neurodegenerative diseases, such as Parkinson’s disease (43, 44), indicating that ATP13A2 and ATP13A3 exert distinct (patho) physiological roles.